Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual preferences, adverse events and physician attitude by Papoutsidakis, N. et al.
Accepted Manuscript
Participation in thrill-seeking activities by patients with
hypertrophic cardiomyopathy: Individual preferences, adverse
events and physician attitude
Nikolaos Papoutsidakis, Stephen Heitner, Jodie Ingles,
Christopher Semsarian, Meghan Mannello, Lisa Salberg, Cynthia
Waldman, Benjamin Vaccaro, Niccolo Maurizi, Iacopo Olivotto,
Daniel Jacoby
PII: S0002-8703(19)30076-6
DOI: https://doi.org/10.1016/j.ahj.2019.04.001
Reference: YMHJ 5869
To appear in: American Heart Journal
Received date: 1 April 2019
Accepted date: 1 April 2019
Please cite this article as: N. Papoutsidakis, S. Heitner, J. Ingles, et al., Participation
in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual
preferences, adverse events and physician attitude, American Heart Journal,
https://doi.org/10.1016/j.ahj.2019.04.001
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IPT
 1 
Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: 
individual preferences, adverse events and physician attitudes. 
Nikolaos Papoutsidakis, MD, PhD
1
, Stephen Heitner, MD
2
, Jodie Ingles, PhD
3
, Christopher 
Semsarian, MD, PhD
3
, Meghan Mannello, MS
2
, Lisa Salberg
4
, Cynthia Waldman
5
, Benjamin 
Vaccaro, MD
1
, Niccolo Maurizi, MD
6
, Iacopo Olivotto, MD
6
, Daniel Jacoby, MD
1 
 
1
Yale School of Medicine, Section of Cardiovascular Medicine, New Haven, CT, USA 
2
Oregon Health & Science University, Knight Cardiovascular Institute Hypertrophic 
Cardiomyopathy and Cardiogenetics Centers, Oregon, USA 
3
Department of Cardiology, Royal Prince Alfred Hospital; Sydney Medical School, University of 
Sydney; Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Australia 
4
Hypertrophic Cardiomyopathy Association, USA 
5
HCMbeat, USA 
6
Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy 
 
 
 
Address for correspondence:  
 
Daniel Jacoby, MD, FACC 
Associate Professor of Medicine (Cardiology) 
Yale School of Medicine 
333 Cedar st, New Haven, CT 06510 
 
Phone 203-785-7191 
Fax 203-785-2917 
Email: daniel.jacoby@yale.edu 
 
 
Word count (with references): 3554 
 
 
Financial support: This research was supported by the Joshua C. Gibson, MD, Memorial Fund 
for Heart Research. 
 
Conflicts of interest/Industry relationships: None relevant 
 
 
 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 2 
Abstract 
Background: Thrill-seeking activities are a favorite pastime for people of all ages. Patients with 
hypertrophic cardiomyopathy (HCM) are often barred from participation on the basis of danger 
for arrhythmias. Our aim was to collect information regarding the safety of thrill-seeking 
activities for HCM patients. 
Methods: An anonymous online survey invited adult HCM patients to report participation in 11 
activities (rollercoaster riding, jet skiing, rafting, bungee jumping, rappelling, paragliding, 
kayaking/canoeing, motor racing, snowboarding, BASE jumping and skydiving) before and after 
HCM diagnosis, along with major (ICD shock, syncope) or minor (nausea, dizziness, 
palpitations, chest pain) adverse events related to participation, and relevant physician advice. 
Results: 647 HCM patients completed the survey, with 571 (88.2%) reporting participation in ≥ 
1 TSAs (participant age 50.85±14.21, 56.6% female, 8143 post-diagnosis participations). At time 
of survey, 457 participants (70.6%) were ICD-carriers or had >=1 risk factor for sudden cardiac 
death. Nine (1.5%) participants reported a major event during or immediately after (60 minutes) 
of surveyed activity. Minor adverse events were reported by 181 participants (31.6%). In 
addition, 8 participants reported a major adverse event >60 minutes later but within the same 
day. Regarding physician advice, of the 213 responders (32.9%) receiving specific advice, 56 
(26.2%) were told safety data is absent with no definitive recommendation, while 24 (11.2%) 
and 93 (43.6%) were told TSAs were respectively safe or dangerous. 
Conclusions: In this cohort, participation in thrill-seeking activities rarely caused major adverse 
events. This information can be used for shared-decision making between providers and patients. 
Abstract word count: 249 
Keywords: hypertrophic cardiomyopathy, thrill-seeking activities, rollercoaster 
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Introduction 
 
Hypertrophic Cardiomyopathy (HCM) is the most common inherited cardiomyopathy and an 
important cause of sudden cardiac death (SCD) in the young
1, 2
. For patients with HCM, intense 
or burst physical exertion that results in rapid increase in heart rate is considered dangerous and 
strongly discouraged by society guidelines
3, 4
.   
 
Along with athletic activities, thrill-seeking activities (TSAs), especially theme park attractions, 
are a very popular pastime worldwide, with an estimated 475.8 million theme park visits in 2017 
for the top 10 industry groups
5
. These activities also cause rapid and intense heart rate increases 
through sympathetic activation in the absence of physical exertion
6, 7
. Despite the popularity of 
TSAs, there is no data on safety for patients with HCM. Participation in TSAs is therefore not 
discussed in most recent HCM guidelines
3
, leaving individual care providers with the burden of 
determining appropriate guidance. 
 
Addressing the issue of safety for HCM patients wishing to participate in TSAs is challenging. 
Prospective studies are difficult to design, mainly for ethical reasons, as amusement park rules 
exclude guests with pre-existing heart conditions from participating. To address these issues, we 
examined the self-reported participation in TSAs of an international HCM patient cohort, 
assessing associated adverse events, physician attitudes towards these activities, patient 
satisfaction and compliance with received advice.   
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Methods 
 
Adult (>18 years) patients with a diagnosis of HCM were invited to complete an anonymous 
online survey (https://is.gd/rollercoasterHCM) regarding participation in 11 TSAs: rollercoaster 
riding, jet skiing, rafting, bungee jumping, rappelling, paragliding, kayaking/canoeing, motor 
racing, snowboarding, BASE jumping and skydiving. Patients were recruited through patient 
advocacy organizations, popular HCM social media outlets, email lists and directly from study 
investigators at the time of clinical visits. Participating HCM expert centers were located in 
North America, Europe and Australia, with online access free to anyone who wished to be 
included in the study. Survey questionnaires assessed: 1) patient demographics, 2) HCM-related 
medical status, including known SCD risk factors and symptoms during everyday activities, 3) 
participation in TSAs in relation to HCM diagnosis (before and/or after), 4) experienced 
symptoms and/or adverse events related to participation (nausea, dizziness, palpitations, chest 
pain, syncope, ICD shock), and 5) physician advice related to participation in TSAs as well as 
non-TSA athletic activities, along with patient satisfaction with the level of advice on a 5-point 
Likert scale. The survey remained open between February and July 2018. Study data were 
collected and managed using REDCap electronic data capture tools hosted at Yale University. 
The study was approved by Yale’s IRB and institutional IRBs at participating centers. 
 
Statistical analyses were performed using IBM SPSS version 24 (Chicago, Illinois). When 
comparing groups, Pearson's chi squared with continuity correction (for nominal variables) or 
Mann-Whitney’s U test (for ordinal variables) were used. For numerical variables, Student’s t-
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test (two-tailed) was used. P-values <=0.05 were considered statistically significant. 
 
Results 
 
Demographics of HCM participants 
 
The survey was completed by 647 HCM patients (“responders”), with 571 (88.2%) reporting 
having participated in ≥ 1 thrill seeking activities (“participants”) in their adult life (age at time 
of survey 50.85±14.21 years). Of those, 229 (40.1%) participated in one or more TSAs before 
being diagnosed with HCM but not after, 292 (51.1%) participated both before and after 
diagnosis, and 50 (8.7%) participated only after their HCM diagnosis. The majority of 
participants were female (326 responders, 56.6%), and residing mostly in North America and 
Australia [417 (73%) and 99 (17.3%), respectively]. This may be partly attributed to the fact that 
survey questions and outreach initiatives were in the English language, possibly also reflecting 
cultural differences and ease of access to TSAs.  
TSA participants’ demographic data is presented in Table 1. 
 
Table 1. TSA participants’ demographics (n=571) 
Age 50.85±14.21 
Sex 
Male 245 (42.9%) 
Female 323 (56.6%) 
Race 
Asian/Pacific 
Islander 
16 (2.8%) 
Black/African 
American 
7 (1.2%) 
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Hispanic/Latino 14 (2.5%) 
White 514 (90%) 
Other 12 (2.1%) 
Residence 
Africa 1 (0.2%) 
Asia 9 (1.6%) 
Australia 99 (17.3%) 
Europe 24 (4.2%) 
North America 417 (73%) 
South America 2 (0.4%) 
 
Responders were also asked about their medical history and clinical status at the time of survey 
(not at time of TSA participation). Clinical information on TSA participants is presented in Table 
2. 
 
Table 2. TSA participants’ clinical information (n=571)* 
Age at diagnosis 39.92 ± 15.89 
NYHA class
†
 
I 195 (34.1%) 
II 126 (22.1%) 
III 155 (27.1%) 
IV 53 (9.3%) 
FHx of SCD 207 (36.3%) 
ICD 256 (44.8%) 
Past ICD shock 77 (30%) 
B-blocker 360 (63%) 
Calcium channel blocker 126 (22.1%) 
Disopyramide 32 (5.6%) 
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Anticoagulation 172 (30.1%) 
Diuretics 140 (24.5%) 
Amiodarone 24 (4.2%) 
Genetic testing performed 327 (57.3%) 
Pathogenic mutation 176 (30.8%) 
Septal 
reduction 
therapy 
Myectomy 135 (23.6%) 
ASA 36 (6.3%) 
LV max thickness 21.05±7.47 
Obstructive HCM 201 (35.2%) 
LVOT grad 99.92±50.59 
Hx of VT 178 (31.2%) 
MRI 339 (59.4%) 
LGE 31 (9.1%) 
Hx of syncope 213 (37.3%) 
High risk for SCD 
‡
 407 (71.2%) 
*
Data represent patient status at time of survey completion, not time of participation or diagnosis. 
†
Based on symptoms during everyday activities at the time of survey. 
‡
Based on history of ICD, syncope, VT, first degree relative with SCD or LV thickness >=30 mm. 
 
Disease Characteristics  
 
At the time of survey completion, a majority (n=334, 66%) of participants reported being 
symptomatic (NYHA class 2-4). Approximately one-third of participants (n=201, 35.2%) 
reported having obstructive HCM based on either general information obtained from their 
doctor, or a self-reported LVOT gradient > 30 mmHg.   
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A strikingly high number of responders (n=457, 70.6%) had ICDs or had at least one established 
risk factor for sudden cardiac death (syncope, ventricular tachycardia, a first-degree relative with 
SCD or LV thickness > 30 mm)
3
. Nearly half (n=256, 44.8%) of those participating in TSAs 
reported having an ICD in place.  
 
The most popular TSAs were rollercoaster riding and kayak/canoeing, reported by 500 (87.5%) 
and 381 (66.7%) patients, respectively. Most patients reported participating in more than one 
activity, with a total of 8143 post-diagnosis participations overall. 
 
Adverse events associated with thrill-seeking activities participation 
 
Reported adverse events were considered TSA-related if they occurred during or immediately 
after (within 60 minutes) the activity and potentially related if they occurred on the day of TSA 
but were temporally unconnected to participation. TSA-related major events (defined as ICD 
shock or syncope) were rare, with 9 (1.5%) participants reporting syncope and no one reporting 
ICD shocks during surveyed activity. Mild symptoms associated with TSAs were more common 
(181 out of 571 patients, 31.6%), with dizziness and palpitations being most often reported 
(24.9% and 20.7% of participants, respectively).  
Regarding potentially related events, 78 participants (13.6%) reported experiencing an adverse 
symptom or event more than an hour later but within the same day, including 8 major events (2 
ICD shocks and 6 syncopal episodes).  
Figure 1 provides a breakdown of participant/non-participant numbers as well as major adverse 
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events related to participation. Table 3 lists symptoms as well as major events reported by 
participants. 
 
Figure 1. Study responders and major events 
 
Figure 1 shows the distribution of study responders, high and low risk patients, participations and major events. All 
major events were syncope. 
 
 
 
Table 3. Adverse events and symptoms from participation (n=571)
* 
 
Yes, during or immediately 
after the activity (within 60 
minutes) 
Yes, more than an hour later 
but within the same day 
Nausea 64 (11.2%) 12 (2.1%) 
Dizziness 142 (24.9%) 31 (5.4%) 
Palpitations 118 (20.7%) 39 (6.8%) 
647 HCM 
responders 
571 
participants 
407 
high risk pts 
6634 TSA 
activities 
4 major 
events 
167 
 low risk pts 
1509 TSA 
activities 
5 major 
events 
76 non-
participants 
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Chest pain 59 (10.3%) 33 (5.8%) 
Syncope 9 (1.5%) 6 (1.1%) 
ICD shock 0 (0%) 2 (0.4%) 
Any symptom or event 191 (33.4%) 78 (13.6%) 
*
Participants could select more than one. Results in table columns are not additive, as participants often reported 
multiple symptoms. 
 
No discernible clinical pattern was seen for the 9 participants who experienced a major event 
during a TSA. Table 4 lists their detailed characteristics. They were evenly distributed in terms 
of gender and presence of high risk features. Three patients did not report heart failure symptoms 
(NYHA class I), while the remaining 6 were symptomatic at baseline.  Age at diagnosis ranged 
from 14-65 years. The most common trigger activity was rollercoaster riding (4 events), which 
was also the most popular thrill-seeking activity in the entire participant cohort. Unfortunately, 
information about the presence of LGE on CMR, a secondary SCD risk factor
8
, was not provided 
by any of the 9 patients. Five out of nine patients reported having participating in TSAs only 
before being diagnosed with HCM (and not after), while 4 reported participation both before and 
after their diagnosis. For those 4 patients, the timing of their TSA-related syncopal event in 
relation to HCM diagnosis (before or after) was not captured. 
 
Table 4. Characteristics of the 9 patients with TSA-related major adverse events
* 
Patient A B C D E F G H I 
Sex M F F F F M M M F 
Age 34 57 48 50 47 56 67 66 50 
Age at 
diagnosis 
14 39 32 50 31 N/A 65 48 47 
Event Syncope Syncope Syncope Syncope Syncope Syncope Syncope Syncope Syncope 
Trigger Racing N/A Roller- Roller- Roller- N/A Roller- Kayak/- N/A 
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activity coaster coaster coaster coaster canoe 
NYHA class III II I IV I II I II IV 
High risk 
features 
†
 
No Yes No No No No Yes Yes Yes 
Obstructive 
HCM 
Yes Yes No Yes No Yes N/A No Yes 
Pathogenic 
mutation 
No test No test N/A Yes No No Yes No test No test 
*
Three additional participants reported an ICD shock in the survey field reserved for TSA-related events, but when 
asked to specify the TSA that triggered it they reported non-surveyed activities (hiking, weight lifting, snow skiing). 
These were added to past ICD shocks in table 2. 
†
History of ventricular tachycardia (sustained or non-sustained), first degree relative with SCD or LV thickness 
>=30 mm. 
N/A: Not available (patient declined to answer) 
 
Figure 2 provides an overview of the number of participants who reported any adverse symptom 
or event, either at the time of participation or as part of their medical history. 
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Figure2.  
 
Number of participants reporting an adverse event, either during TSA participation, on the same day or as part of 
their medical history. 
 
Physician attitudes and advice provided to patients  
 
Table 5 contains information about physician advice provided to patients regarding participation 
in TSA or sports activities, as well as patient satisfaction in having their questions answered. All 
647 survey responders are included (TSA participants and non-participants). Patients referred to 
an HCM expert center by their primary care provider/cardiologist were asked to report advice 
received there, with results stratified according to expert center referral or not.  
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Table 5. Physician advice and patient satisfaction 
 
Referred to 
expert center 
(n=429) 
Not referred to 
expert center
*
 
(n=199) 
p 
Participants 387 (90.2%) 169 (84.9%) 
0.152 
Non-participants 42 (9.8%) 30 (15.1%) 
Advice provided by 
physicians on thrill-
seeking activity 
participation 
Safe 17 (4%) 7 (3.5%) 
0.377 
Dangerous 72 (16.8%) 20 (10.1%) 
Limited data on 
safety 
40 (9.3%) 16 (8%) 
No advice 257 (59.9%) 145 (72.9%) 
Advice provided by 
physicians on sports 
participation 
Avoid all exercise 16 (3.7%) 9 (4.5%) 
0.055 
Avoid strenuous 
exercise but 
maintain fitness 
294 (68.5%) 108 (54.3%) 
No restrictions on 
exercise 
15 (3.5%) 11 (5.5%) 
No advice 74 (17.2%) 49 (24.6%) 
Patient satisfaction on received advice (all 
activities) (5=Very satisfied, 1=Very 
dissatisfied) 
4.1±0.77 3.75±0.66 <0.001 
*
Or did not know/not sure. Responders who did not provide relevant information are not included. 
 
Physician Advice Regarding TSA Participation 
 
In total, 213 responders (32.9%) reported receiving advice specifically on TSAs. Of those, 130 
(61%) reported that their doctors spontaneously offered advice on TSAs, while 83 (38.9%) had 
to specifically ask their doctors about participation.  Fifty-six patients (26.2%) were told that 
safety data is absent for such activities and were therefore given no definitive recommendation, 
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while 24 (11.2%) and 93 (43.6%) were told that participation was respectively safe or dangerous. 
The remaining 40 patients replied “Other (I received different advice)” or declined to provide 
additional information.  
 
We also investigated patient compliance with proffered advice, by examining the subgroup of 
patients who used to participate in TSAs before their diagnosis and then received specific advice 
(safe to participate, dangerous or limited safety data) (n=124). Sixteen of the 19 pre-diagnosis 
participants (84.2%) who were told participation is safe continued participating after their 
diagnosis, but so did 37 out of the 64 (53.1%) who were told it was dangerous. Of the 41 subjects 
who were informed that safety data is limited, the majority (35 subjects, 85.3%) decided not to 
abandon TSAs after their diagnosis.  
 
Physician Advice Regarding non-TSA Athletic Activities 
 
We additionally explored physician advice concerning athletic activities. A majority (n=490, 
75.7%) of responders received sports participation advice, whereas 126 (19.4%) received no 
guidance from their providers regarding non-TSA athletic activities. Fifty-three (10.8%) received 
extreme guidance by their physicians (complete avoidance of any exertion or complete freedom 
to participate in any athletics), including 31 patients who reportedly had been referred to an 
HCM expert center. Having high risk features for SCD did not seem to significantly influence 
the type of advice provided to participants concerning safety of either thrill-seeking or physical 
activities. 
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In general, satisfaction levels with physician advice were high, with 159 responders reporting 
being very satisfied (score of 5), and only 18 being very dissatisfied (score of 1) with received 
advice. Patients who had been referred to an HCM expert center were overall more satisfied with 
their doctor’s advice regarding their lifestyle, with an average Likert score of 4.1±0.77 vs. 
3.75±0.66 (p<0.001).  
 
Discussion 
 
This is the first study to directly investigate safety in thrill seeking activities among HCM 
patients. The main finding of this study is that in a large cohort of TSA participants, most of 
whom had at least one high risk feature for SCD, major events (ICD shocks, syncopal episodes) 
during or immediately after a TSA were rare. Milder symptoms, predominantly dizziness, were 
commonly reported but did not appear significantly increased compared with the symptoms of 
daily life. In addition, we found that physicians’ advice regarding TSAs was fragmented, even 
when offered in HCM expert centers, ranging from complete freedom to direct prohibition of 
participation. 
 
Physiology of TSA Participation 
The differential between theoretical concerns based on understanding of physiology and 
presumed arrhythmic mechanism, and real observed risk is an important region to explore.   
Based on information available from studies in healthy volunteers, safety concerns for HCM 
patients who participate in TSAs are not unfounded
6, 7, 9
. Physiological changes from the thrill of 
participation can be substantial, with burst increases in heart rate despite little or no physical 
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exertion. Even in TSAs where some physical action is required, such as parachute jumping, heart 
rate correlates mostly with emotional state rather than exertion, and may reach levels close to or 
above the age-predicted maximum
10
. Further, though not specifically TSAs, there is an 
established link between SCD and emotionally intense events such as earthquakes
11
 or even 
while watching sports
12
.   
 
This could be concerning for HCM patients, as sympathetic activation, along with tachycardia-
induced increased oxygen demands, might be expected to increase atrial or ventricular 
arrhythmias.  Primary physiologic data during TSAs are limited. In three small studies observing 
a total of 88 healthy volunteers (20 children), continuous ECG monitoring was undertaken 
during a roller coaster ride
6, 7, 9
. Sinus tachycardia was the predominant rhythm observed, with 
only one 4-second episode of atrial fibrillation and one 3-beat episode of NSVT recorded.   
 
While our retrospective survey cannot comment directly on arrhythmia prevalence during 
participation, in a population enriched with ICDs (44%) no shocks were delivered, suggesting a 
low TSA-induced burden of life-threatening arrhythmias, even in high-risk patients. This is in 
agreement with a growing body of literature showing overall low arrhythmic propensity in HCM 
patients during activities that were previously considered stressful
13, 14
. These data suggest that 
extrapolation of current thinking on physiologic stress response may not accurately predict 
observed risk.  
 
Mortality 
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The retrospective nature of this study limits our ability to assess for mortality.  Publicly available 
data for the overall population of theme park visitors suggests that arrhythmias leading to death 
are uncommon. A study using publicly available information on deaths related to rollercoaster 
riding reported 7 cases of SCD (including 3 in children) between 1994-2004, with no mention of 
specific causes
15
. For context, the overall number of rollercoaster deaths during the same decade 
was 40, and these were primarily caused by traumatic injuries. More recent data from the 
Saferparks database (www.saferparks.org), covering approximately 8,000 amusement ride 
accident reports from 28 state agencies and the U.S. Consumer Product Safety Commission (for 
the years 2011-2016), as well as the National Electronic Injury Surveillance System hospital 
admissions data (2013-2017) (https://saferparksdata.org/explore-hospital-data), reported a total 
of 7 cardiac deaths possibly related to amusement rides, with none specifically attributed to pre-
existing hypertrophic cardiomyopathy. 
 The low number of deaths over the span of several years makes significant survival bias unlikely 
in our study, at least regarding rollercoaster rides. It remains possible that non-reported fatalities 
from participation in TSAs outside of theme parks exist. 
 
HCM Participants vs General Population  
We observed 1.5% of participants with reported major events, all syncopal episodes, during and 
around the time of TSA.  This is similar to the proportion of like events in the general 
population. The Saferparks database reported 88 loss of consciousness events between 1986-
2008 (including seizures) in patrons over 18 years of age visiting U.S amusement parks, 
accounting for 1.7% of total reported accidents. Interestingly, an additional 8 respondents of our 
survey reported syncope or ICD shock on the same day as TSA participation, but not during or 
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within 60 minutes, suggesting that factors other than direct TSA participation may drive 
symptoms on the day of the event (e.g. hot sun, alcohol intake, fatigue). Other symptoms related 
to participation, such as dizziness, are also commonly reported by healthy individuals visiting 
theme park attractions
16
.  
 
Physician Attitudes 
In addition to identifying adverse events related to TSAs, we also sought to explore physicians’ 
attitudes towards participation, as reflected in advice provided to patients. Impressively, most 
physicians did not provide any guidance, while a significant portion of those who did were 
prompted by direct patient queries on the topic. Further, advice specifics were inconsistent, even 
amongst HCM expert centers. This is not unexpected, as guidance for doctors in published 
guidelines is lacking, probably due to paucity of data. While current ACC/AHA guidelines grade 
recreational sports activities according to their acceptability for HCM patients
3
, TSAs do not 
receive direct attention. Older recommendations on inherited cardiomyopathies warned 
specifically against amusement park rides, but specified that risk was greatest for patients with 
catecholamine-sensitive or auditory-triggered arrhythmia syndromes such as LQTS and CPVT
17
.  
 
Physicians’ advice was more uniform concerning participation in sports activities. The majority 
of doctors advised their HCM patients to avoid strenuous activity as potentially dangerous but 
encouraged patients to maintain their fitness. This is in accordance with current society 
guidelines
3
.  Importantly, a prospective study is underway to further elucidate the safety profile 
of physical exertion in HCM patients (LIVE-HCM, ClinicalTrials ID: NCT02549664). A 
minority of patients reported receiving extreme advice (avoid all physical activity or participate 
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in sports without restrictions). Extreme advice contradicts available evidence and 
recommendations, both as regards absolute restriction and permission to participate fully
18
.  
 
It is interesting to note that patients referred to expert centers reported being more satisfied, on 
average, with received advice for participating in TSAs and/or sports.  Expert centers did not shy 
away from giving potentially limiting restrictions (most referred patients were told to avoid high 
intensity sports and TSAs) so it is clear that satisfaction did not depend on patients getting 
permissive advice. This, however, contrasts with the low compliance with received advice. Being 
warned that TSAs were dangerous or that safety data is limited did not deter most patients who 
enjoyed TSAs before they were diagnosed from continuing to do so. Participating in TSAs is 
clearly important for a significant number of HCM patients, therefore prospective studies 
rigorously testing the safety of this behavior may be needed. 
 
Limitations of the study 
 
This study relied on self-reported information and therefore is subject to recall and selection 
biases. In addition, the possibility of survival bias cannot be excluded; however, we believe a 
significant effect is unlikely for reasons discussed above. Patient clinical information reflected 
their status at time of survey completion, not necessarily at time of participation, so any 
correlations between clinical status and participation in TSAs have to be interpreted cautiously. 
Some HCM patient races and/or ethnicities were under-represented in the study, as responder 
population consisted only of English-speaking patients.  
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The study cohort was highly enriched in patients with risk factors for SCD, as well as patients 
with advanced heart failure at the time of survey (NYHA class III-IV). This is not a 
representative sample of the general HCM patient population
5
. We believe this to be partly due 
to a selection effect, as sicker and/or high-risk HCM patients tend to be more involved with their 
disease by joining patient advocacy groups, interacting in social media outlets, as well as having 
more often follow-up clinic visits. This increased the chances of exposure to our survey. An 
alternative explanation may be that some patients with ICDs felt “protected” from arrhythmias 
and preferentially participated in TSAs. Regardless of true reason, high-risk patients are expected 
to be more vulnerable to pro-arrhythmic stimuli and therefore their inclusion in large numbers 
adds sensitivity to the study.  
 
Conclusions 
 
Thrill-seeking activities are popular amongst HCM patients, despite lack of safety data and often 
contrary advice from caregivers. We found that participation in thrill-seeking activities was 
overall safe, with rare major events.  Whether these data are sufficiently robust to reassure expert 
clinician and/or patient concerns based on current thinking about the physiology of stress 
response in HCM patients remains to be seen.  Since this is the first study examining TSAs in the 
HCM population, it will benefit from prospective validation.  In the meantime, providers may 
consider incorporating this data into discussions with patients at the time of diagnosis and 
follow-up. 
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